Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in Europe

Abstract: Patient-reported outcomes (PROs) give direct insights into the treatment’s impact on patient’s life and complement clinical outcomes. However, since the advent of chimeric antigen receptor T-cell therapy (CAR-T), PROs have been underreported. Particularly, little is known about long-term h...

Cijeli opis

Bibliografski detalji

Glavni autori:	Elise R. A. Pennings, Anne M. Spanjaart, Frederick W. Thielen, Simone Oerlemans, Anna Fleischer, Carmen Sanges, Maria Gomes Da Silva, Yolanda Cabrerizo, Pacôme Lecot, Lutgart Roux-Opstaele, Caroline Dreuillet, Eglys Gonzalez-Marcano, Olga Millán, Ulrich Jaeger, Julio Delgado, Maik Luu, Barbara Huber, Margot Lorrain, Mariana Pina, Andreas Kremer, Natacha Bolaños, Solène Clavreul, Samantha Nier, Roberto D. K. Liu, Birgit I. Lissenberg-Witte, Sébastien Anguille, Marie Robin, Emma C. Morris, Anna Sureda, Marie Préau, Myriam Pannard, Geertruida H. De Bock, Scott S. Wagers, Hélène Negre, Delphine Maucort-Boulch, Michael Hudecek, Carin A. Uyl-de Groot, Marie José Kersten
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2025-12-01
Serija:	Blood Advances
Online pristup:	http://www.sciencedirect.com/science/article/pii/S2473952925005889
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!